ArticleJournal of general internal medicine2022

Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease.

Rebecca L Tisdale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.